Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kristen A Stout

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Journal of Neuroscience Methods|June 16, 2012
A fluorescent-based assay for live cell, spatially resolved assessment of vesicular monoamine transporter 2-mediated neurotransmitter transportAlison I Bernstein, Kristen A Stout, Gary W Miller
Neurochemistry International|January 9, 2014
The vesicular monoamine transporter 2: an underexplored pharmacological targetAlison I Bernstein, Kristen A Stout, Gary W Miller
ACS Chemical Neuroscience|August 9, 2019
The Synaptic Vesicle Glycoprotein 2: Structure, Function, and Disease RelevanceKristen A Stout, Amy R Dunn, Carlie Hoffman, et al.
Medical Sciences (Basel, Switzerland)|October 31, 2017
Alteration to Dopaminergic Synapses Following Exposure to Perfluorooctane Sulfonate (PFOS), in Vitro and in VivoRahul Patel, Joshua M Bradner, Kristen A Stout, et al.
Brain Research|December 25, 2017
Immunochemical analysis of the expression of SV2C in mouse, macaque and human brainAmy R Dunn, Carlie A Hoffman, Kristen A Stout, et al.
ACS Chemical Neuroscience|March 10, 2015
Increased Vesicular Monoamine Transporter 2 (VMAT2; Slc18a2) Protects against Methamphetamine ToxicityKelly M Lohr, Kristen A Stout, Amy R Dunn, et al.
ACS Chemical Neuroscience|August 9, 2016
Selective Enhancement of Dopamine Release in the Ventral Pallidum of Methamphetamine-Sensitized MiceKristen A Stout, Amy R Dunn, Kelly M Lohr, et al.
Experimental Neurology|October 3, 2015
Reduced vesicular monoamine transport disrupts serotonin signaling but does not cause serotonergic degenerationShawn P Alter, Kristen A Stout, Kelly M Lohr, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|June 12, 2016
Vesicular Monoamine Transporter 2 (VMAT2) Level Regulates MPTP Vulnerability and Clearance of Excess Dopamine in Mouse Striatal TerminalsKelly M Lohr, Merry Chen, Carlie A Hoffman, et al.
Synapse (New York, N.Y.)|November 29, 2011
Methamphetamine self-administration acutely decreases monoaminergic transporter functionLisa M McFadden, Kristen A Stout, Paula L Vieira-Brock, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Journal of Neuroscience Methods|June 16, 2012
A fluorescent-based assay for live cell, spatially resolved assessment of vesicular monoamine transporter 2-mediated neurotransmitter transportAlison I Bernstein, Kristen A Stout, Gary W Miller
Neurochemistry International|January 9, 2014
The vesicular monoamine transporter 2: an underexplored pharmacological targetAlison I Bernstein, Kristen A Stout, Gary W Miller
ACS Chemical Neuroscience|August 9, 2019
The Synaptic Vesicle Glycoprotein 2: Structure, Function, and Disease RelevanceKristen A Stout, Amy R Dunn, Carlie Hoffman, et al.
Medical Sciences (Basel, Switzerland)|October 31, 2017
Alteration to Dopaminergic Synapses Following Exposure to Perfluorooctane Sulfonate (PFOS), in Vitro and in VivoRahul Patel, Joshua M Bradner, Kristen A Stout, et al.
Brain Research|December 25, 2017
Immunochemical analysis of the expression of SV2C in mouse, macaque and human brainAmy R Dunn, Carlie A Hoffman, Kristen A Stout, et al.
ACS Chemical Neuroscience|March 10, 2015
Increased Vesicular Monoamine Transporter 2 (VMAT2; Slc18a2) Protects against Methamphetamine ToxicityKelly M Lohr, Kristen A Stout, Amy R Dunn, et al.
ACS Chemical Neuroscience|August 9, 2016
Selective Enhancement of Dopamine Release in the Ventral Pallidum of Methamphetamine-Sensitized MiceKristen A Stout, Amy R Dunn, Kelly M Lohr, et al.
Experimental Neurology|October 3, 2015
Reduced vesicular monoamine transport disrupts serotonin signaling but does not cause serotonergic degenerationShawn P Alter, Kristen A Stout, Kelly M Lohr, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|June 12, 2016
Vesicular Monoamine Transporter 2 (VMAT2) Level Regulates MPTP Vulnerability and Clearance of Excess Dopamine in Mouse Striatal TerminalsKelly M Lohr, Merry Chen, Carlie A Hoffman, et al.
Synapse (New York, N.Y.)|November 29, 2011
Methamphetamine self-administration acutely decreases monoaminergic transporter functionLisa M McFadden, Kristen A Stout, Paula L Vieira-Brock, et al.
Pageof 3